

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.63817101 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.28307162 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.01395734 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.94610537 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.63777490 |
| 6 | response to peptidoglycan (GO:0032494) | 4.23139745 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.22625059 |
| 8 | vocalization behavior (GO:0071625) | 4.20673852 |
| 9 | neurotransmitter secretion (GO:0007269) | 4.15204308 |
| 10 | proline transport (GO:0015824) | 4.11706185 |
| 11 | activation of protein kinase A activity (GO:0034199) | 4.02809935 |
| 12 | mannose metabolic process (GO:0006013) | 4.01664604 |
| 13 | glutamate secretion (GO:0014047) | 3.96705397 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.94902175 |
| 15 | gamma-aminobutyric acid transport (GO:0015812) | 3.88021071 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.87554695 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.83315450 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.82770157 |
| 19 | synaptic vesicle endocytosis (GO:0048488) | 3.82187502 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 3.82064980 |
| 21 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.80605723 |
| 22 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.79137325 |
| 23 | sodium ion export (GO:0071436) | 3.76450477 |
| 24 | exploration behavior (GO:0035640) | 3.75594336 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.74249910 |
| 26 | cerebellar Purkinje cell layer development (GO:0021680) | 3.70122631 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.67769187 |
| 28 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.65209742 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.60767223 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.60767223 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.60767223 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.60767223 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.60767223 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.60767223 |
| 35 | cellular potassium ion homeostasis (GO:0030007) | 3.60263902 |
| 36 | glycosphingolipid catabolic process (GO:0046479) | 3.60034585 |
| 37 | cell communication by electrical coupling (GO:0010644) | 3.55217278 |
| 38 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.48752800 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48417452 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.47282702 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.46961481 |
| 42 | * neuromuscular process controlling posture (GO:0050884) | 3.46956210 |
| 43 | neuronal action potential propagation (GO:0019227) | 3.46574142 |
| 44 | neuron cell-cell adhesion (GO:0007158) | 3.45051752 |
| 45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.44456617 |
| 46 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.43584627 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.42999329 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.41911153 |
| 49 | neurotransmitter transport (GO:0006836) | 3.40500430 |
| 50 | layer formation in cerebral cortex (GO:0021819) | 3.39672553 |
| 51 | mating behavior (GO:0007617) | 3.37322554 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.36990686 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 3.36794459 |
| 54 | glycine transport (GO:0015816) | 3.32009910 |
| 55 | pinocytosis (GO:0006907) | 3.29048317 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.25954156 |
| 57 | protein localization to synapse (GO:0035418) | 3.24926661 |
| 58 | * neuromuscular process controlling balance (GO:0050885) | 3.22754233 |
| 59 | barbed-end actin filament capping (GO:0051016) | 3.21591217 |
| 60 | glycolipid catabolic process (GO:0019377) | 3.18793989 |
| 61 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.18412999 |
| 62 | oligosaccharide catabolic process (GO:0009313) | 3.17955324 |
| 63 | protein localization to endosome (GO:0036010) | 3.15664359 |
| 64 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.14965556 |
| 65 | amino sugar catabolic process (GO:0046348) | 3.14378449 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.09670430 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.01936952 |
| 68 | detection of external biotic stimulus (GO:0098581) | 3.01747783 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00734220 |
| 70 | detection of other organism (GO:0098543) | 3.00153222 |
| 71 | long-term memory (GO:0007616) | 2.99406793 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 2.98822615 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98684343 |
| 74 | proline biosynthetic process (GO:0006561) | 2.95809637 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95567322 |
| 76 | regulation of glutamate secretion (GO:0014048) | 2.94109929 |
| 77 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.93869891 |
| 78 | vesicle transport along microtubule (GO:0047496) | 2.93826518 |
| 79 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.93622563 |
| 80 | glutamate receptor signaling pathway (GO:0007215) | 2.92542579 |
| 81 | alanine transport (GO:0032328) | 2.89919497 |
| 82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.88413211 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88397715 |
| 84 | neuron recognition (GO:0008038) | 2.86835360 |
| 85 | regulation of female receptivity (GO:0045924) | 2.86721950 |
| 86 | synaptic transmission, glutamatergic (GO:0035249) | 2.85491508 |
| 87 | regulation of mast cell degranulation (GO:0043304) | 2.85086631 |
| 88 | dendritic spine morphogenesis (GO:0060997) | 2.84531496 |
| 89 | cell migration in hindbrain (GO:0021535) | 2.84395225 |
| 90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84203101 |
| 91 | negative regulation of cell killing (GO:0031342) | 2.84203101 |
| 92 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.83532564 |
| 93 | regulation of extracellular matrix disassembly (GO:0010715) | 2.82379784 |
| 94 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.82305965 |
| 95 | neuronal ion channel clustering (GO:0045161) | 2.82100626 |
| 96 | detection of bacterium (GO:0016045) | 2.81840273 |
| 97 | * neuromuscular process (GO:0050905) | 2.81270943 |
| 98 | prepulse inhibition (GO:0060134) | 2.80668122 |
| 99 | regulation of vesicle fusion (GO:0031338) | 2.79138847 |
| 100 | transmission of nerve impulse (GO:0019226) | 2.78961463 |
| 101 | potassium ion import (GO:0010107) | 2.78259303 |
| 102 | axonal fasciculation (GO:0007413) | 2.77691700 |
| 103 | low-density lipoprotein particle clearance (GO:0034383) | 2.77671292 |
| 104 | neuron-neuron synaptic transmission (GO:0007270) | 2.76918028 |
| 105 | response to histamine (GO:0034776) | 2.76765549 |
| 106 | response to laminar fluid shear stress (GO:0034616) | 2.76512169 |
| 107 | detection of biotic stimulus (GO:0009595) | 2.76099317 |
| 108 | membrane depolarization during action potential (GO:0086010) | 2.76064271 |
| 109 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75882065 |
| 110 | regulation of postsynaptic membrane potential (GO:0060078) | 2.74317047 |
| 111 | regulation of synaptic plasticity (GO:0048167) | 2.73648901 |
| 112 | regulation of apoptotic cell clearance (GO:2000425) | 2.73317247 |
| 113 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.72778428 |
| 114 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71972026 |
| 115 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.71437526 |
| 116 | regulation of cholesterol storage (GO:0010885) | 2.71132374 |
| 117 | regulation of respiratory system process (GO:0044065) | 2.70764512 |
| 118 | response to thyroid hormone (GO:0097066) | 2.68911815 |
| 119 | potassium ion homeostasis (GO:0055075) | 2.68842610 |
| 120 | amyloid precursor protein catabolic process (GO:0042987) | 2.68696218 |
| 121 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.68546668 |
| 122 | female mating behavior (GO:0060180) | 2.68516001 |
| 123 | ceramide catabolic process (GO:0046514) | 2.67842446 |
| 124 | adhesion of symbiont to host (GO:0044406) | 2.67292259 |
| 125 | apoptotic cell clearance (GO:0043277) | 2.66876719 |
| 126 | organelle transport along microtubule (GO:0072384) | 2.64312945 |
| 127 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.64293005 |
| 128 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63666922 |
| 129 | response to auditory stimulus (GO:0010996) | 2.63461772 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.62643645 |
| 131 | dopamine receptor signaling pathway (GO:0007212) | 2.62553214 |
| 132 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62544640 |
| 133 | cellular sodium ion homeostasis (GO:0006883) | 2.62542739 |
| 134 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62256573 |
| 135 | positive regulation of membrane potential (GO:0045838) | 2.62203493 |
| 136 | macrophage activation (GO:0042116) | 2.61849518 |
| 137 | neurotransmitter catabolic process (GO:0042135) | 2.61318901 |
| 138 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.60828417 |
| 139 | oxygen transport (GO:0015671) | 2.60744315 |
| 140 | negative regulation of amino acid transport (GO:0051956) | 2.60606119 |
| 141 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.60312529 |
| 142 | cell-cell junction maintenance (GO:0045217) | 2.60285583 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.59837950 |
| 144 | positive regulation of phagocytosis (GO:0050766) | 2.59213677 |
| 145 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.59159965 |
| 146 | response to parathyroid hormone (GO:0071107) | 2.58184666 |
| 147 | positive regulation of receptor recycling (GO:0001921) | 2.57759514 |
| 148 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57607792 |
| 149 | germinal center formation (GO:0002467) | 2.56911503 |
| 150 | N-acetylneuraminate metabolic process (GO:0006054) | 2.56389310 |
| 151 | intraspecies interaction between organisms (GO:0051703) | 2.56051820 |
| 152 | social behavior (GO:0035176) | 2.56051820 |
| 153 | stress fiber assembly (GO:0043149) | 2.55586958 |
| 154 | signal complex assembly (GO:0007172) | 2.54729816 |
| 155 | regulation of beta-amyloid formation (GO:1902003) | 2.54594597 |
| 156 | signal release (GO:0023061) | 2.54484066 |
| 157 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.54270501 |
| 158 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.54093814 |
| 159 | suckling behavior (GO:0001967) | 2.53849586 |
| 160 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.53824269 |
| 161 | regulation of early endosome to late endosome transport (GO:2000641) | 2.53675768 |
| 162 | peptide catabolic process (GO:0043171) | 2.52815470 |
| 163 | establishment of synaptic vesicle localization (GO:0097480) | 2.52503480 |
| 164 | synaptic vesicle transport (GO:0048489) | 2.52503480 |
| 165 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.51464665 |
| 166 | semaphorin-plexin signaling pathway (GO:0071526) | 2.50156037 |
| 167 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49722226 |
| 168 | modulation by symbiont of host cellular process (GO:0044068) | 2.48485016 |
| 169 | virion attachment to host cell (GO:0019062) | 2.48194398 |
| 170 | adhesion of symbiont to host cell (GO:0044650) | 2.48194398 |
| 171 | glucose 6-phosphate metabolic process (GO:0051156) | 2.46316409 |
| 172 | positive regulation of cholesterol efflux (GO:0010875) | 2.45670090 |
| 173 | basement membrane organization (GO:0071711) | 2.44549208 |
| 174 | regulation of superoxide anion generation (GO:0032928) | 2.43545789 |
| 175 | NIK/NF-kappaB signaling (GO:0038061) | 2.41467788 |
| 176 | hyaluronan catabolic process (GO:0030214) | 2.38575757 |
| 177 | regulation of macrophage chemotaxis (GO:0010758) | 2.38358761 |
| 178 | adenosine receptor signaling pathway (GO:0001973) | 2.38250156 |
| 179 | myeloid dendritic cell differentiation (GO:0043011) | 2.36733335 |
| 180 | regulation of regulated secretory pathway (GO:1903305) | 2.36255739 |
| 181 | regulation of extracellular matrix organization (GO:1903053) | 2.36005520 |
| 182 | sphingolipid catabolic process (GO:0030149) | 2.35098792 |
| 183 | membrane lipid catabolic process (GO:0046466) | 2.33920866 |
| 184 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.32649957 |
| 185 | T-helper 1 type immune response (GO:0042088) | 2.31554594 |
| 186 | complement activation, alternative pathway (GO:0006957) | 2.31489810 |
| 187 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30905267 |
| 188 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.30582431 |
| 189 | regulation of mononuclear cell migration (GO:0071675) | 2.30348225 |
| 190 | cellular extravasation (GO:0045123) | 2.30173911 |
| 191 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.29552398 |
| 192 | negative regulation of granulocyte differentiation (GO:0030853) | 2.29020809 |
| 193 | regulation of phagocytosis (GO:0050764) | 2.28143139 |
| 194 | granulocyte activation (GO:0036230) | 2.28072154 |
| 195 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.25480864 |
| 196 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.25480864 |
| 197 | positive regulation of mast cell degranulation (GO:0043306) | 2.24589010 |
| 198 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.24589010 |
| 199 | protein retention in ER lumen (GO:0006621) | 2.23993220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.56780776 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.20928987 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.80726121 |
| 4 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.76986316 |
| 5 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.73474515 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.66334547 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65838953 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.64261834 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60613583 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.60406630 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53806093 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53461306 |
| 13 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.40905002 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.39337906 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37667031 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32278206 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.30560748 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.29898283 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28457721 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28018737 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22445907 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22445907 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21272152 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20574709 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11311850 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09974965 |
| 27 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.05512162 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03746880 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03036348 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02633099 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.01801465 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.00801959 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00760000 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00134321 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99823725 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95945327 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95214455 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94643354 |
| 39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93111090 |
| 40 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.90623239 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.88276751 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87687038 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84817146 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84022786 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83947733 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.80669319 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80148214 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78834672 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.78300823 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76115357 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.75835944 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71280169 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70104573 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.69176920 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.67709954 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.67607191 |
| 57 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.66839298 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66447921 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65239533 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62687298 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62293764 |
| 62 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.61092809 |
| 63 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57398602 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53907783 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.52971543 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51341722 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48573961 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48559811 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48542843 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48488308 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47561573 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45972027 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44938299 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43755734 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.38989173 |
| 76 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.37533534 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35650200 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35545612 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35171740 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35077895 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34274174 |
| 82 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33890230 |
| 83 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33840781 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.32611799 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32430723 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32268776 |
| 87 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32135300 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32132718 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31839429 |
| 90 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30762863 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29068313 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28972245 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28953136 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28533181 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.26917022 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23820779 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23315577 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22331607 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21435220 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20570956 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19864965 |
| 102 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19853475 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18430748 |
| 104 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17518510 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17273639 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17050036 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16950136 |
| 108 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15991687 |
| 109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15923856 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15201091 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14165622 |
| 112 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.12561369 |
| 113 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12326657 |
| 114 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12195273 |
| 115 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11878348 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11395197 |
| 117 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11352192 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10930240 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10431145 |
| 120 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.09202591 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 1.08803857 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08029995 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07943580 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06265113 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06126262 |
| 126 | AR_19668381_ChIP-Seq_PC3_Human | 1.04874477 |
| 127 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04843020 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03496644 |
| 129 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.03380203 |
| 130 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01624924 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01565026 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00768948 |
| 133 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00385871 |
| 134 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00248999 |
| 135 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99969035 |
| 136 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.99882192 |
| 137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99761281 |
| 138 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98690293 |
| 139 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98537544 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98251727 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98018068 |
| 142 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.97904480 |
| 143 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97834331 |
| 144 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97354614 |
| 145 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96602771 |
| 146 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94530815 |
| 147 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94121449 |
| 148 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93237190 |
| 149 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92536390 |
| 150 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.92472869 |
| 151 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89788897 |
| 152 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89604768 |
| 153 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87796389 |
| 154 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86421191 |
| 155 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86118457 |
| 156 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.85365799 |
| 157 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84972987 |
| 158 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.83698005 |
| 159 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82387710 |
| 160 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.79868722 |
| 161 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.77958795 |
| 162 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77888411 |
| 163 | P68_20966046_ChIP-Seq_HELA_Human | 0.77723521 |
| 164 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77070056 |
| 165 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.76995862 |
| 166 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.76109264 |
| 167 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.76001594 |
| 168 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.75709644 |
| 169 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75470315 |
| 170 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.73318214 |
| 171 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.72823330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.34525367 |
| 2 | * MP0005058_abnormal_lysosome_morphology | 4.74066898 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.58385978 |
| 4 | MP0003880_abnormal_central_pattern | 3.58043229 |
| 5 | MP0003303_peritoneal_inflammation | 3.50640288 |
| 6 | MP0009840_abnormal_foam_cell | 3.22124368 |
| 7 | MP0003122_maternal_imprinting | 3.19735069 |
| 8 | MP0003436_decreased_susceptibility_to | 3.19454527 |
| 9 | MP0009046_muscle_twitch | 2.95948366 |
| 10 | MP0002064_seizures | 2.94556012 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.88167651 |
| 12 | MP0009745_abnormal_behavioral_response | 2.84353507 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.82893902 |
| 14 | MP0003283_abnormal_digestive_organ | 2.81679453 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.79467038 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.61278233 |
| 17 | MP0002822_catalepsy | 2.58179113 |
| 18 | MP0006082_CNS_inflammation | 2.56234673 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.54553659 |
| 20 | MP0005451_abnormal_body_composition | 2.52822041 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.50069178 |
| 22 | MP0003724_increased_susceptibility_to | 2.48458687 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.45356626 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.36756480 |
| 25 | MP0004270_analgesia | 2.32159092 |
| 26 | MP0008260_abnormal_autophagy | 2.26097544 |
| 27 | MP0005423_abnormal_somatic_nervous | 2.25882178 |
| 28 | MP0002419_abnormal_innate_immunity | 2.25843099 |
| 29 | MP0004233_abnormal_muscle_weight | 2.21904267 |
| 30 | MP0001501_abnormal_sleep_pattern | 2.16720536 |
| 31 | MP0002272_abnormal_nervous_system | 2.15639391 |
| 32 | MP0002733_abnormal_thermal_nociception | 2.12845605 |
| 33 | MP0004510_myositis | 2.12490143 |
| 34 | MP0000013_abnormal_adipose_tissue | 2.06945015 |
| 35 | MP0004858_abnormal_nervous_system | 2.03192074 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.99159422 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.96278231 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.96083488 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.95920998 |
| 40 | MP0009278_abnormal_bone_marrow | 1.92770976 |
| 41 | MP0001970_abnormal_pain_threshold | 1.88685853 |
| 42 | MP0005025_abnormal_response_to | 1.86850077 |
| 43 | MP0003329_amyloid_beta_deposits | 1.85473664 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.80413310 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.79868917 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.79307862 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.78239322 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.77238198 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.75011046 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.74484510 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.72424421 |
| 52 | MP0009785_altered_susceptibility_to | 1.71062320 |
| 53 | MP0000858_altered_metastatic_potential | 1.68647750 |
| 54 | MP0001486_abnormal_startle_reflex | 1.67880955 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.66792147 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.65158949 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.63869406 |
| 58 | MP0001849_ear_inflammation | 1.62805068 |
| 59 | MP0002254_reproductive_system_inflammat | 1.62527086 |
| 60 | MP0002067_abnormal_sensory_capabilities | 1.60234740 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.59177494 |
| 62 | MP0003123_paternal_imprinting | 1.58532629 |
| 63 | MP0001790_abnormal_immune_system | 1.57864473 |
| 64 | MP0005387_immune_system_phenotype | 1.57864473 |
| 65 | MP0004947_skin_inflammation | 1.57627797 |
| 66 | MP0002736_abnormal_nociception_after | 1.55722841 |
| 67 | MP0000343_altered_response_to | 1.54878252 |
| 68 | MP0004924_abnormal_behavior | 1.54538124 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.54538124 |
| 70 | MP0000685_abnormal_immune_system | 1.53753203 |
| 71 | MP0004811_abnormal_neuron_physiology | 1.52468022 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.52351865 |
| 73 | MP0004142_abnormal_muscle_tone | 1.50919799 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.50293274 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.43915479 |
| 76 | MP0000955_abnormal_spinal_cord | 1.42510038 |
| 77 | MP0008569_lethality_at_weaning | 1.41628560 |
| 78 | MP0003279_aneurysm | 1.41153233 |
| 79 | MP0005623_abnormal_meninges_morphology | 1.40389401 |
| 80 | MP0001958_emphysema | 1.39533163 |
| 81 | MP0008961_abnormal_basal_metabolism | 1.38300591 |
| 82 | MP0003091_abnormal_cell_migration | 1.37861124 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.37304858 |
| 84 | MP0002184_abnormal_innervation | 1.34940598 |
| 85 | MP0003633_abnormal_nervous_system | 1.34591080 |
| 86 | MP0002557_abnormal_social/conspecific_i | 1.34512503 |
| 87 | * MP0002066_abnormal_motor_capabilities/c | 1.31845942 |
| 88 | MP0002452_abnormal_antigen_presenting | 1.30721833 |
| 89 | MP0002735_abnormal_chemical_nociception | 1.29057064 |
| 90 | MP0003183_abnormal_peptide_metabolism | 1.28729260 |
| 91 | MP0008004_abnormal_stomach_pH | 1.28270976 |
| 92 | MP0002723_abnormal_immune_serum | 1.26190017 |
| 93 | MP0005257_abnormal_intraocular_pressure | 1.25772650 |
| 94 | MP0004885_abnormal_endolymph | 1.24760367 |
| 95 | MP0003045_fibrosis | 1.22989699 |
| 96 | MP0003828_pulmonary_edema | 1.22827218 |
| 97 | MP0008469_abnormal_protein_level | 1.22462057 |
| 98 | MP0005171_absent_coat_pigmentation | 1.20721127 |
| 99 | MP0005365_abnormal_bile_salt | 1.19542455 |
| 100 | * MP0000751_myopathy | 1.18416491 |
| 101 | MP0001845_abnormal_inflammatory_respons | 1.16732198 |
| 102 | MP0005671_abnormal_response_to | 1.16244056 |
| 103 | MP0003787_abnormal_imprinting | 1.15364901 |
| 104 | MP0000639_abnormal_adrenal_gland | 1.13810125 |
| 105 | MP0005409_darkened_coat_color | 1.13306701 |
| 106 | MP0003075_altered_response_to | 1.13078691 |
| 107 | MP0010155_abnormal_intestine_physiology | 1.12136250 |
| 108 | MP0002882_abnormal_neuron_morphology | 1.11752011 |
| 109 | MP0001853_heart_inflammation | 1.11220243 |
| 110 | MP0005390_skeleton_phenotype | 1.10615751 |
| 111 | MP0003448_altered_tumor_morphology | 1.10319973 |
| 112 | MP0005360_urolithiasis | 1.09885606 |
| 113 | MP0005166_decreased_susceptibility_to | 1.09311905 |
| 114 | MP0001819_abnormal_immune_cell | 1.09022743 |
| 115 | MP0002420_abnormal_adaptive_immunity | 1.07842933 |
| 116 | MP0004130_abnormal_muscle_cell | 1.07519036 |
| 117 | MP0002405_respiratory_system_inflammati | 1.07399279 |
| 118 | MP0003879_abnormal_hair_cell | 1.07028975 |
| 119 | MP0002933_joint_inflammation | 1.06658982 |
| 120 | MP0001800_abnormal_humoral_immune | 1.06511683 |
| 121 | MP0005023_abnormal_wound_healing | 1.06109650 |
| 122 | MP0004883_abnormal_blood_vessel | 1.05983988 |
| 123 | MP0005164_abnormal_response_to | 1.04969287 |
| 124 | MP0000920_abnormal_myelination | 1.04583938 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 1.04036683 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 1.03925916 |
| 127 | MP0001545_abnormal_hematopoietic_system | 1.03925916 |
| 128 | MP0001529_abnormal_vocalization | 1.03689328 |
| 129 | MP0003634_abnormal_glial_cell | 1.00774962 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 1.00737514 |
| 131 | MP0000767_abnormal_smooth_muscle | 1.00467305 |
| 132 | MP0003631_nervous_system_phenotype | 0.99547897 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.98003069 |
| 134 | MP0008874_decreased_physiological_sensi | 0.97002753 |
| 135 | MP0005535_abnormal_body_temperature | 0.96280053 |
| 136 | MP0000778_abnormal_nervous_system | 0.95151040 |
| 137 | MP0003690_abnormal_glial_cell | 0.94808916 |
| 138 | MP0002069_abnormal_eating/drinking_beha | 0.94720462 |
| 139 | MP0006054_spinal_hemorrhage | 0.94496454 |
| 140 | MP0009764_decreased_sensitivity_to | 0.94077800 |
| 141 | MP0001905_abnormal_dopamine_level | 0.92818186 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.90764459 |
| 143 | MP0010234_abnormal_vibrissa_follicle | 0.89470397 |
| 144 | MP0002896_abnormal_bone_mineralization | 0.89068997 |
| 145 | * MP0002269_muscular_atrophy | 0.87138071 |
| 146 | MP0003795_abnormal_bone_structure | 0.86935534 |
| 147 | MP0002152_abnormal_brain_morphology | 0.86786844 |
| 148 | MP0000249_abnormal_blood_vessel | 0.85076474 |
| 149 | MP0008872_abnormal_physiological_respon | 0.84189441 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.83761574 |
| 151 | MP0003121_genomic_imprinting | 0.83378888 |
| 152 | MP0003646_muscle_fatigue | 0.82699468 |
| 153 | MP0001915_intracranial_hemorrhage | 0.82618212 |
| 154 | MP0001851_eye_inflammation | 0.82299740 |
| 155 | MP0002229_neurodegeneration | 0.80868762 |
| 156 | MP0005310_abnormal_salivary_gland | 0.79816838 |
| 157 | * MP0000747_muscle_weakness | 0.79661050 |
| 158 | MP0000604_amyloidosis | 0.77988796 |
| 159 | MP0005165_increased_susceptibility_to | 0.77811278 |
| 160 | MP0000678_abnormal_parathyroid_gland | 0.76377218 |
| 161 | MP0005167_abnormal_blood-brain_barrier | 0.75424564 |
| 162 | MP0001542_abnormal_bone_strength | 0.75015489 |
| 163 | MP0004085_abnormal_heartbeat | 0.74455594 |
| 164 | MP0004185_abnormal_adipocyte_glucose | 0.74043758 |
| 165 | MP0005375_adipose_tissue_phenotype | 0.73839107 |
| 166 | MP0010386_abnormal_urinary_bladder | 0.72485403 |
| 167 | MP0005448_abnormal_energy_balance | 0.72410873 |
| 168 | MP0000716_abnormal_immune_system | 0.71636735 |
| 169 | MP0002653_abnormal_ependyma_morphology | 0.71608339 |
| 170 | MP0002108_abnormal_muscle_morphology | 0.71467238 |
| 171 | MP0001984_abnormal_olfaction | 0.69821822 |
| 172 | MP0000609_abnormal_liver_physiology | 0.69086521 |
| 173 | MP0004036_abnormal_muscle_relaxation | 0.68709823 |
| 174 | MP0002332_abnormal_exercise_endurance | 0.67162185 |
| 175 | MP0003959_abnormal_lean_body | 0.66607890 |
| 176 | MP0001943_abnormal_respiration | 0.63869669 |
| 177 | MP0001299_abnormal_eye_distance/ | 0.63865025 |
| 178 | MP0004133_heterotaxia | 0.63700318 |
| 179 | MP0004215_abnormal_myocardial_fiber | 0.63317215 |
| 180 | MP0003953_abnormal_hormone_level | 0.62963521 |
| 181 | * MP0003137_abnormal_impulse_conducting | 0.62848833 |
| 182 | MP0000681_abnormal_thyroid_gland | 0.62252311 |
| 183 | MP0004381_abnormal_hair_follicle | 0.59973396 |
| 184 | MP0002060_abnormal_skin_morphology | 0.59798268 |
| 185 | * MP0002078_abnormal_glucose_homeostasis | 0.59360706 |
| 186 | MP0008877_abnormal_DNA_methylation | 0.58312325 |
| 187 | MP0000631_abnormal_neuroendocrine_gland | 0.58237999 |
| 188 | MP0002089_abnormal_postnatal_growth/wei | 0.57487285 |
| 189 | MP0003632_abnormal_nervous_system | 0.54321118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.37420946 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.37420946 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.37420946 |
| 4 | Myokymia (HP:0002411) | 5.11917651 |
| 5 | Focal motor seizures (HP:0011153) | 5.09735245 |
| 6 | Visual hallucinations (HP:0002367) | 4.79854480 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.75294326 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.21258214 |
| 9 | Focal seizures (HP:0007359) | 4.20930164 |
| 10 | Atonic seizures (HP:0010819) | 4.19438041 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.76923775 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.73838965 |
| 13 | Absence seizures (HP:0002121) | 3.69070108 |
| 14 | Hypercortisolism (HP:0001578) | 3.59992933 |
| 15 | Turricephaly (HP:0000262) | 3.57515710 |
| 16 | Loss of speech (HP:0002371) | 3.52243705 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43765509 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.35318362 |
| 19 | Glomerulonephritis (HP:0000099) | 3.35146201 |
| 20 | Failure to thrive in infancy (HP:0001531) | 3.30398741 |
| 21 | Pheochromocytoma (HP:0002666) | 3.28256005 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.27680002 |
| 23 | Dialeptic seizures (HP:0011146) | 3.22195059 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 3.16950069 |
| 25 | Complement deficiency (HP:0004431) | 3.13251959 |
| 26 | Febrile seizures (HP:0002373) | 3.11391992 |
| 27 | Deep venous thrombosis (HP:0002625) | 3.07046918 |
| 28 | Action tremor (HP:0002345) | 3.04780854 |
| 29 | Annular pancreas (HP:0001734) | 3.04048107 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.03612389 |
| 31 | Epileptic encephalopathy (HP:0200134) | 3.03172670 |
| 32 | Axonal loss (HP:0003447) | 3.02884757 |
| 33 | Depression (HP:0000716) | 3.01188166 |
| 34 | Abnormality of complement system (HP:0005339) | 2.98584603 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.96608552 |
| 36 | Abnormality of the lower motor neuron (HP:0002366) | 2.92984399 |
| 37 | Vertebral compression fractures (HP:0002953) | 2.91987685 |
| 38 | Amyloidosis (HP:0011034) | 2.91894806 |
| 39 | Growth hormone excess (HP:0000845) | 2.91874316 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 2.91644607 |
| 41 | Nuclear cataract (HP:0100018) | 2.90098112 |
| 42 | Abnormal eating behavior (HP:0100738) | 2.84665721 |
| 43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.83872094 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.83141306 |
| 45 | Ankle clonus (HP:0011448) | 2.81367807 |
| 46 | Narrow nasal bridge (HP:0000446) | 2.79313856 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.75420065 |
| 48 | Purpura (HP:0000979) | 2.72881917 |
| 49 | Neuroendocrine neoplasm (HP:0100634) | 2.71930633 |
| 50 | Menstrual irregularities (HP:0000858) | 2.70800338 |
| 51 | Anxiety (HP:0000739) | 2.70489835 |
| 52 | Postural instability (HP:0002172) | 2.68042540 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.66576613 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.65462303 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.62597680 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.58716274 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58716274 |
| 58 | Polyphagia (HP:0002591) | 2.57551202 |
| 59 | Hypoventilation (HP:0002791) | 2.57292713 |
| 60 | Orchitis (HP:0100796) | 2.53920510 |
| 61 | Myositis (HP:0100614) | 2.50537486 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.49804342 |
| 63 | Agitation (HP:0000713) | 2.48556938 |
| 64 | Cervical subluxation (HP:0003308) | 2.47006633 |
| 65 | Disinhibition (HP:0000734) | 2.46036964 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44002946 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44002946 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44002946 |
| 69 | Status epilepticus (HP:0002133) | 2.39846416 |
| 70 | Myocardial infarction (HP:0001658) | 2.39451127 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.38670170 |
| 72 | Protrusio acetabuli (HP:0003179) | 2.37043268 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.36847177 |
| 74 | Mutism (HP:0002300) | 2.32974194 |
| 75 | Oligomenorrhea (HP:0000876) | 2.32569755 |
| 76 | Impaired social interactions (HP:0000735) | 2.30375154 |
| 77 | Abnormal social behavior (HP:0012433) | 2.30375154 |
| 78 | Neurofibrillary tangles (HP:0002185) | 2.29788467 |
| 79 | Hemiplegia (HP:0002301) | 2.29367519 |
| 80 | Dysmetria (HP:0001310) | 2.28853742 |
| 81 | Thin bony cortex (HP:0002753) | 2.28007233 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.27379721 |
| 83 | Bradykinesia (HP:0002067) | 2.27016979 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.25416403 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.24730693 |
| 86 | Pathologic fracture (HP:0002756) | 2.22114542 |
| 87 | Gingivitis (HP:0000230) | 2.19923195 |
| 88 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.18822015 |
| 89 | Poor eye contact (HP:0000817) | 2.18813686 |
| 90 | Torticollis (HP:0000473) | 2.18684058 |
| 91 | Truncal ataxia (HP:0002078) | 2.17300632 |
| 92 | Thoracic kyphosis (HP:0002942) | 2.16815097 |
| 93 | Rapidly progressive (HP:0003678) | 2.16776906 |
| 94 | Increased serum ferritin (HP:0003281) | 2.14573312 |
| 95 | Apathy (HP:0000741) | 2.13402529 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 2.12296558 |
| 97 | Mediastinal lymphadenopathy (HP:0100721) | 2.11102809 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 2.10709003 |
| 99 | Papilledema (HP:0001085) | 2.08870104 |
| 100 | Diminished motivation (HP:0000745) | 2.08855345 |
| 101 | Progressive neurologic deterioration (HP:0002344) | 2.08415071 |
| 102 | Joint stiffness (HP:0001387) | 2.07661527 |
| 103 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06470223 |
| 104 | Psychosis (HP:0000709) | 2.05479294 |
| 105 | Optic neuritis (HP:0100653) | 2.04838498 |
| 106 | Retrobulbar optic neuritis (HP:0100654) | 2.04838498 |
| 107 | Intention tremor (HP:0002080) | 2.03371506 |
| 108 | Hyperparathyroidism (HP:0000843) | 2.03343630 |
| 109 | Fetal akinesia sequence (HP:0001989) | 2.02990743 |
| 110 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.02502323 |
| 111 | Abnormality of the thoracic spine (HP:0100711) | 2.01328522 |
| 112 | Increased connective tissue (HP:0009025) | 2.00313903 |
| 113 | Bone pain (HP:0002653) | 1.99458081 |
| 114 | Broad face (HP:0000283) | 1.98209242 |
| 115 | Premature rupture of membranes (HP:0001788) | 1.98178834 |
| 116 | Nephritis (HP:0000123) | 1.97726716 |
| 117 | Coronal craniosynostosis (HP:0004440) | 1.96870798 |
| 118 | Poor suck (HP:0002033) | 1.96437691 |
| 119 | Adrenal overactivity (HP:0002717) | 1.95471896 |
| 120 | Insomnia (HP:0100785) | 1.94992021 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.93885702 |
| 122 | Clumsiness (HP:0002312) | 1.93528342 |
| 123 | Obstructive sleep apnea (HP:0002870) | 1.93365369 |
| 124 | Xanthomatosis (HP:0000991) | 1.91774328 |
| 125 | Resting tremor (HP:0002322) | 1.89597874 |
| 126 | Neoplasm of the heart (HP:0100544) | 1.89431094 |
| 127 | Abnormality of pain sensation (HP:0010832) | 1.88891363 |
| 128 | Impaired pain sensation (HP:0007328) | 1.88891363 |
| 129 | Hyperacusis (HP:0010780) | 1.88797742 |
| 130 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88785393 |
| 131 | Focal dystonia (HP:0004373) | 1.88352887 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87499586 |
| 133 | Obstructive lung disease (HP:0006536) | 1.87499586 |
| 134 | Postural tremor (HP:0002174) | 1.87238841 |
| 135 | Limb dystonia (HP:0002451) | 1.87051278 |
| 136 | Macroorchidism (HP:0000053) | 1.86289705 |
| 137 | Epileptiform EEG discharges (HP:0011182) | 1.85982997 |
| 138 | Rigidity (HP:0002063) | 1.85848735 |
| 139 | Hypsarrhythmia (HP:0002521) | 1.85545055 |
| 140 | Genetic anticipation (HP:0003743) | 1.85318714 |
| 141 | Bundle branch block (HP:0011710) | 1.85133477 |
| 142 | Achilles tendon contracture (HP:0001771) | 1.84952452 |
| 143 | Abnormality of the labia minora (HP:0012880) | 1.84484426 |
| 144 | Myotonia (HP:0002486) | 1.84425081 |
| 145 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84347881 |
| 146 | Dysmetric saccades (HP:0000641) | 1.83960400 |
| 147 | Upper limb amyotrophy (HP:0009129) | 1.83417099 |
| 148 | Distal upper limb amyotrophy (HP:0007149) | 1.83417099 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.83023822 |
| 150 | Polygenic inheritance (HP:0010982) | 1.82056056 |
| 151 | Prolonged neonatal jaundice (HP:0006579) | 1.81886321 |
| 152 | Hepatosplenomegaly (HP:0001433) | 1.81662600 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.81466604 |
| 154 | Craniofacial dystonia (HP:0012179) | 1.81260664 |
| 155 | Joint hemorrhage (HP:0005261) | 1.79589144 |
| 156 | Hemiparesis (HP:0001269) | 1.79076823 |
| 157 | Lower limb muscle weakness (HP:0007340) | 1.78910933 |
| 158 | Spondylolisthesis (HP:0003302) | 1.78765845 |
| 159 | Flat acetabular roof (HP:0003180) | 1.78668944 |
| 160 | Deformed sella turcica (HP:0002681) | 1.78185763 |
| 161 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.77086146 |
| 162 | Clonus (HP:0002169) | 1.76933867 |
| 163 | Generalized myoclonic seizures (HP:0002123) | 1.76081551 |
| 164 | Dementia (HP:0000726) | 1.75693097 |
| 165 | Hypokinesia (HP:0002375) | 1.74893054 |
| 166 | Testicular neoplasm (HP:0010788) | 1.71535063 |
| 167 | Congenital glaucoma (HP:0001087) | 1.70627784 |
| 168 | Abnormality of the periventricular white matter (HP:0002518) | 1.70450931 |
| 169 | Recurrent skin infections (HP:0001581) | 1.70391349 |
| 170 | Large for gestational age (HP:0001520) | 1.69943928 |
| 171 | Distal lower limb amyotrophy (HP:0008944) | 1.68437804 |
| 172 | Malnutrition (HP:0004395) | 1.68279981 |
| 173 | Abnormality of the lumbar spine (HP:0100712) | 1.67065592 |
| 174 | Personality changes (HP:0000751) | 1.65582039 |
| 175 | Ovoid vertebral bodies (HP:0003300) | 1.64994031 |
| 176 | Peritonitis (HP:0002586) | 1.64274056 |
| 177 | Cellulitis (HP:0100658) | 1.63069287 |
| 178 | Esophageal varix (HP:0002040) | 1.62598527 |
| 179 | Peripheral demyelination (HP:0011096) | 1.62380476 |
| 180 | Mitral stenosis (HP:0001718) | 1.61617455 |
| 181 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.61322314 |
| 182 | Colitis (HP:0002583) | 1.61159901 |
| 183 | Bulbar palsy (HP:0001283) | 1.61029457 |
| 184 | * Cerebral aneurysm (HP:0004944) | 1.59963365 |
| 185 | Hypertriglyceridemia (HP:0002155) | 1.58864339 |
| 186 | Increased IgE level (HP:0003212) | 1.58581389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.98938502 |
| 2 | MAP3K9 | 3.94603259 |
| 3 | ERN1 | 3.49525953 |
| 4 | DDR2 | 2.99805892 |
| 5 | ICK | 2.72999614 |
| 6 | IRAK3 | 2.71053154 |
| 7 | EPHA4 | 2.52296266 |
| 8 | PINK1 | 2.30805476 |
| 9 | MAP3K4 | 2.30145639 |
| 10 | NTRK1 | 2.29185784 |
| 11 | MAP2K3 | 2.14484552 |
| 12 | ARAF | 2.08458917 |
| 13 | NTRK2 | 2.08309448 |
| 14 | TYRO3 | 2.03752107 |
| 15 | SMG1 | 1.99651023 |
| 16 | BLK | 1.99514550 |
| 17 | MAP3K3 | 1.98396707 |
| 18 | UHMK1 | 1.98125766 |
| 19 | NME2 | 1.93751899 |
| 20 | TYK2 | 1.92153716 |
| 21 | PHKG1 | 1.89653503 |
| 22 | PHKG2 | 1.89653503 |
| 23 | KSR2 | 1.88488072 |
| 24 | PAK6 | 1.86657914 |
| 25 | PRKD3 | 1.86576914 |
| 26 | MAPK15 | 1.85009820 |
| 27 | MINK1 | 1.82784542 |
| 28 | FGFR4 | 1.80862504 |
| 29 | PDGFRA | 1.74468501 |
| 30 | MAP3K6 | 1.74048835 |
| 31 | LATS2 | 1.72278208 |
| 32 | DAPK1 | 1.69066419 |
| 33 | EPHB1 | 1.66778848 |
| 34 | MAP2K4 | 1.66553281 |
| 35 | MAP3K12 | 1.64326778 |
| 36 | TGFBR2 | 1.62167778 |
| 37 | TBK1 | 1.60872926 |
| 38 | PKN2 | 1.57814758 |
| 39 | TAOK2 | 1.56768447 |
| 40 | MAP3K11 | 1.52537334 |
| 41 | STK38 | 1.45164718 |
| 42 | TTN | 1.41333282 |
| 43 | BMX | 1.38022607 |
| 44 | CSK | 1.37538476 |
| 45 | ZAP70 | 1.35477762 |
| 46 | CAMKK1 | 1.33815290 |
| 47 | MAP2K7 | 1.33305838 |
| 48 | MAP3K14 | 1.32869618 |
| 49 | TRIB3 | 1.32384570 |
| 50 | TESK1 | 1.31850119 |
| 51 | IRAK4 | 1.30160367 |
| 52 | EEF2K | 1.29391741 |
| 53 | FGR | 1.29113718 |
| 54 | MAP4K1 | 1.29020630 |
| 55 | EPHA2 | 1.28212934 |
| 56 | PRKD2 | 1.24264166 |
| 57 | MARK1 | 1.24107847 |
| 58 | PAK4 | 1.20652467 |
| 59 | CDK5 | 1.20451964 |
| 60 | CDC42BPA | 1.18452026 |
| 61 | LMTK2 | 1.18128124 |
| 62 | TNK2 | 1.16736292 |
| 63 | DAPK2 | 1.12605907 |
| 64 | CSF1R | 1.11981035 |
| 65 | TAOK1 | 1.11210356 |
| 66 | PTK6 | 1.10063866 |
| 67 | MATK | 1.08924240 |
| 68 | MAP3K13 | 1.07119578 |
| 69 | GRK5 | 1.04060108 |
| 70 | PRKCH | 1.02731541 |
| 71 | RPS6KA2 | 0.98679828 |
| 72 | SCYL2 | 0.96517768 |
| 73 | CAMK2A | 0.94713339 |
| 74 | PAK3 | 0.92661323 |
| 75 | JAK3 | 0.92471330 |
| 76 | ALK | 0.92118457 |
| 77 | CDK12 | 0.88389838 |
| 78 | AKT3 | 0.88165311 |
| 79 | MAP3K1 | 0.87954530 |
| 80 | CAMK1D | 0.87450134 |
| 81 | RIPK1 | 0.86871706 |
| 82 | PRKCG | 0.86590481 |
| 83 | CAMK2G | 0.82418096 |
| 84 | TESK2 | 0.82395367 |
| 85 | RAF1 | 0.82380868 |
| 86 | SIK2 | 0.82234440 |
| 87 | IRAK2 | 0.79792288 |
| 88 | SIK3 | 0.76131318 |
| 89 | JAK1 | 0.76075435 |
| 90 | PIM2 | 0.75018902 |
| 91 | RET | 0.73293393 |
| 92 | MAP3K2 | 0.73152279 |
| 93 | CAMK2B | 0.72237667 |
| 94 | KSR1 | 0.70561883 |
| 95 | CAMKK2 | 0.69766339 |
| 96 | PDK1 | 0.69206138 |
| 97 | MTOR | 0.68953852 |
| 98 | CAMK2D | 0.68896466 |
| 99 | MAPK7 | 0.68667483 |
| 100 | CDK15 | 0.67959268 |
| 101 | FES | 0.66189354 |
| 102 | GRK6 | 0.65067701 |
| 103 | NEK1 | 0.64923363 |
| 104 | CDK18 | 0.64728011 |
| 105 | FER | 0.64262478 |
| 106 | CDK14 | 0.63472844 |
| 107 | IKBKB | 0.63225567 |
| 108 | HIPK2 | 0.62842616 |
| 109 | HCK | 0.62598829 |
| 110 | MAP2K6 | 0.61583801 |
| 111 | CAMK1 | 0.58859594 |
| 112 | JAK2 | 0.58290802 |
| 113 | STK11 | 0.58156172 |
| 114 | MAPK12 | 0.57920925 |
| 115 | SGK1 | 0.57852278 |
| 116 | IKBKE | 0.57725596 |
| 117 | ABL2 | 0.57689355 |
| 118 | PTK2 | 0.57678632 |
| 119 | CDK11A | 0.57256989 |
| 120 | CHUK | 0.55781610 |
| 121 | MARK2 | 0.55661578 |
| 122 | CAMK1G | 0.54884784 |
| 123 | FGFR3 | 0.54842858 |
| 124 | PLK2 | 0.54627208 |
| 125 | PRPF4B | 0.54528837 |
| 126 | MST1R | 0.53846602 |
| 127 | MAP3K7 | 0.53055368 |
| 128 | RPS6KA3 | 0.52684703 |
| 129 | PNCK | 0.52617601 |
| 130 | PDGFRB | 0.51926486 |
| 131 | MAPK10 | 0.50690293 |
| 132 | PRKAA1 | 0.49922177 |
| 133 | SIK1 | 0.47354440 |
| 134 | CDK19 | 0.46620628 |
| 135 | LRRK2 | 0.46574587 |
| 136 | MAP2K2 | 0.46555083 |
| 137 | RPS6KC1 | 0.46112248 |
| 138 | RPS6KL1 | 0.46112248 |
| 139 | BTK | 0.46035790 |
| 140 | CDK6 | 0.45973788 |
| 141 | RIPK4 | 0.45411745 |
| 142 | SGK3 | 0.44954424 |
| 143 | PDPK1 | 0.42728133 |
| 144 | MAPKAPK2 | 0.42369083 |
| 145 | DYRK1B | 0.42127034 |
| 146 | PRKCZ | 0.40970360 |
| 147 | EPHB2 | 0.40859172 |
| 148 | PRKG2 | 0.40722173 |
| 149 | MOS | 0.39569430 |
| 150 | LYN | 0.38793345 |
| 151 | IRAK1 | 0.38326109 |
| 152 | SGK494 | 0.37012651 |
| 153 | SGK223 | 0.37012651 |
| 154 | PRKD1 | 0.36997931 |
| 155 | CSNK1G2 | 0.34768745 |
| 156 | PRKACG | 0.34631743 |
| 157 | MAP2K1 | 0.33866246 |
| 158 | GRK7 | 0.32899255 |
| 159 | PTK2B | 0.32178382 |
| 160 | RPS6KA6 | 0.32138896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.60927967 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.28411233 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.23096415 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80899915 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.67553696 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66997722 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.47363465 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31464565 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25470035 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16114029 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.12434737 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.07694045 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.06810324 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.05773588 |
| 15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.05381669 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92262854 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90390773 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.90229213 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.86438290 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.86060072 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82794464 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.82622636 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82247724 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.80616041 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79255935 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.75282776 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.70247267 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.67616905 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62737920 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.62217687 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57015677 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.56901974 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51200452 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51145145 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.49314677 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45297424 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.43094077 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40824980 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.40612261 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38991415 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.36466396 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.36318749 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35166445 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.31805018 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.31573622 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30678308 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28837948 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27974807 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27842441 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27367663 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27097098 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23093867 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.21988808 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18669580 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17812333 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17266271 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 1.16740525 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 1.14556229 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14262551 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10344977 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09141088 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09032763 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.06946189 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06669243 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04230461 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04157332 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03427502 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 1.00523431 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00449557 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00195886 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00172203 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 1.00126741 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99596495 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97542625 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96595716 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95953945 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95832488 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95485712 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94903993 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.94249797 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90772531 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89499146 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.87918754 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87759550 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87125348 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.86752776 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.85930816 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84940766 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84703132 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84083647 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83986597 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83108084 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83094918 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82966333 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82924352 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.82199718 |
| 97 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.81837240 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81550283 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78449457 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77478269 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77085500 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75536291 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75484329 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.74784026 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.74566137 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73319243 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72721030 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72226099 |
| 109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72122883 |
| 110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71981981 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71827890 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71201351 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71147089 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70237145 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.69956444 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69163769 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.68141422 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67627016 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67077358 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64894736 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64498805 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63722465 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63318974 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62601045 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62094262 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61447320 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61250020 |
| 128 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61136036 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61023753 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60998460 |
| 131 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60768737 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60088685 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59837440 |
| 134 | * Lysosome_Homo sapiens_hsa04142 | 0.58607048 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.58487136 |
| 136 | Focal adhesion_Homo sapiens_hsa04510 | 0.57926240 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.56941128 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56664716 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56035498 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55330166 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54595917 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.54411179 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52901851 |
| 144 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52696305 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52417926 |
| 146 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51516054 |
| 147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51487877 |
| 148 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50782670 |
| 149 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50706861 |
| 150 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50645655 |
| 151 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49309448 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47959212 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.47779669 |
| 154 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47212637 |
| 155 | Axon guidance_Homo sapiens_hsa04360 | 0.47020541 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43958643 |
| 157 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43788526 |
| 158 | Bladder cancer_Homo sapiens_hsa05219 | 0.43510104 |
| 159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43058076 |
| 160 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42110289 |
| 161 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42047654 |
| 162 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40771021 |
| 163 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39038499 |
| 164 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38510725 |
| 165 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38110050 |
| 166 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36407198 |
| 167 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36316975 |
| 168 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34660814 |
| 169 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31983965 |

